StockNews.com Begins Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)
Stock analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Shares of Titan Pharmaceuticals stock opened at $3.84 on Friday. The firm has a market […]
